$GTLL
GLOBAL TECHNOLOGIES LTD Stock $gtll

$gtll Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223005657 Filed on February 21, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue		$14.00K	$45.00K
YoY Change		-68.89%
Cost Of Revenue
YoY Change
Gross Profit		$14.00K	$45.00K
YoY Change		-68.89%
Gross Profit Margin		100.0%	100.0%
Selling, General & Admin	$4.497K	$10.31K	$88.25K
YoY Change	-96.33%	-88.31%	-35.59%
% of Gross Profit		73.67%	196.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.298K	$1.298K	$1.300K
YoY Change	-0.15%	-0.15%	71.05%
% of Gross Profit		9.27%	2.89%
Operating Expenses	$46.30K	$38.51K	$89.56K
YoY Change	-62.63%	-57.0%	-35.0%
Operating Profit	-$46.30K	-$24.51K	-$44.56K
YoY Change	-58.86%	-44.99%	-67.66%
Interest Expense	-$622.1K	$208.2K	$393.7K
YoY Change	199.5%	-47.11%	-102.09%
% of Operating Profit
Other Income/Expense, Net	-$622.1K	$208.2K	$376.9K
YoY Change	129.77%	-44.74%
Pretax Income	-$668.4K	$183.7K	$332.3K
YoY Change	74.38%	-44.71%	-101.75%
Income Tax
% Of Pretax Income
Net Earnings	-$668.4K	$183.7K	$332.3K
YoY Change	74.38%	-44.71%	-101.75%
Net Earnings / Revenue		1312.31%	738.47%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$27.64
COMMON SHARES
Basic Shares Outstanding	14.49B shares	14.45B shares
Diluted Shares Outstanding	14.49B shares	14.49B shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$70.00	$617.8K
YoY Change	-100.0%	-99.99%	11826.06%
Cash & Equivalents		$69.00	$617.8K
Short-Term Investments
Other Short-Term Assets			$0.00
YoY Change
Inventory
Prepaid Expenses
Receivables	$5.000K	$5.000K	$40.00K
Other Receivables	$17.53K	$17.53K	$18.66K
Total Short-Term Assets	$43.19K	$38.95K	$676.4K
YoY Change	-94.08%	-94.24%	4925.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.05K	$20.35K	$25.54K
YoY Change	-21.41%	-20.33%	-19.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$369.1K	$370.3K
YoY Change
Total Long-Term Assets	$369.1K	$370.3K	$648.9K
YoY Change	-50.63%	-42.92%	-47.18%
TOTAL ASSETS
Total Short-Term Assets	$43.19K	$38.95K	$676.4K
Total Long-Term Assets	$369.1K	$370.3K	$648.9K
Total Assets	$412.2K	$409.3K	$1.325M
YoY Change	-72.09%	-69.12%	6.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$52.69K	$33.15K	$2.730K
YoY Change	1217.33%	1114.36%	-99.47%
Accrued Expenses	$105.0K	$77.59K	$29.52K
YoY Change	199.63%	162.84%	-88.93%
Deferred Revenue
YoY Change
Short-Term Debt	$307.6K	$302.3K	$319.3K
YoY Change	-28.34%	-5.33%	-68.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.653M	$981.7K	$971.9K
YoY Change	41.62%	1.01%	-95.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.653M	$981.7K	$971.9K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.653M	$981.7K	$971.9K
YoY Change	41.62%	1.01%	-95.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$167.0M	-$166.3M
YoY Change
Common Stock	$164.4M	$164.4M
YoY Change
Preferred Stock	$1.385M	$1.385M
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.241M	-$572.4K	$353.4K
YoY Change
Total Liabilities & Shareholders Equity	$412.2K	$409.3K	$1.325M
YoY Change	-72.09%	-69.12%	6.71%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$668.4K	$183.7K	$332.3K
YoY Change	74.38%	-44.71%	-101.75%
Depreciation, Depletion And Amortization	$1.298K	$1.298K	$1.300K
YoY Change	-0.15%	-0.15%	71.05%
Cash From Operating Activities	-$5.450K	-$3.580K	-$57.06K
YoY Change	-96.19%	-93.73%	-159.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$150.0K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00	$0.00	-$150.0K
YoY Change	-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.390K	0.000	758.5K
YoY Change	-97.88%	-100.0%	-822.73%
NET CHANGE
Cash From Operating Activities	-5.450K	-3.580K	-57.06K
Cash From Investing Activities	0.000	0.000	-150.0K
Cash From Financing Activities	5.390K	0.000	758.5K
Net Change In Cash	-60.00	-3.580K	551.4K
YoY Change	-100.54%	-100.65%	-6767.96%
FREE CASH FLOW
Cash From Operating Activities	-$5.450K	-$3.580K	-$57.06K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000932021
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q4	GTLL	Forgiveness Of Debt And Accrued Interest ForgivenessOfDebtAndAccruedInterest		usd
	GTLL	Forgiveness Of Debt And Accrued Interest ForgivenessOfDebtAndAccruedInterest		usd
CY2022Q4	GTLL	Gain Loss On Issuance On Notes Payable GainLossOnIssuanceOnNotesPayable		usd
	GTLL	Gain Loss On Issuance On Notes Payable GainLossOnIssuanceOnNotesPayable		usd
CY2022Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	1385113	usd
CY2021Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2021Q4	GTLL	Cashless Exercise Of Warrant CashlessExerciseOfWarrant		usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2022Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent		usd
	GTLL	Return Of Common Share Value ReturnOfCommonShareValue		usd
	GTLL	Cashless Exercise Of Warrant CashlessExerciseOfWarrant		usd
	GTLL	Gain From Forgiveness Of Debt And Interest GainFromForgivenessOfDebtAndInterest		usd
	GTLL	Loss On Issuance On Notes Payable LossOnIssuanceOnNotesPayable		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities		usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	GTLL	Proceeds From Issuance Of Stock For Regulation Financing ProceedsFromIssuanceOfStockForRegulationFinancing		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	GTLL	Cancellation Of Common Stock And Stock To Be Issued CancellationOfCommonStockAndStockToBeIssued		usd
	GTLL	Cancellation Of Common Stock As Per Court Order CancellationOfCommonStockAsPerCourtOrder		usd
	GTLL	Issuance Of Common Stock For Debt And Accrued Interest IssuanceOfCommonStockForDebtAndAccruedInterest		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q2	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet		usd
CY2022Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent		usd
	GTLL	Forgiveness Of Debt Including Accrued Interest ForgivenessOfDebtIncludingAccruedInterest		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-25668
	dei	Entity Registrant Name EntityRegistrantName	GLOBAL TECHNOLOGIES, LTD
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0970492
	dei	Entity Address Address Line1 EntityAddressAddressLine1	510 1st Ave N.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 901
	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Petersburg
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33701
	dei	City Area Code CityAreaCode	(727)
	dei	Local Phone Number LocalPhoneNumber	482-1505
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	GTLL
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14488440097	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	324494	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166320069	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166444337	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	16343	usd
CY2022Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	7521	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	17533	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	18380	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	38945	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	355395	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16015	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13419	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20348	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22944	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	350000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	350000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	370348	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	372944	usd
CY2022Q4	us-gaap	Assets Assets	409293	usd
CY2022Q2	us-gaap	Assets Assets	728339	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	33152	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	15562	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	59515	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	47839	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	18074	usd
CY2022Q4	GTLL	Notes Payable Third Parties Current NotesPayableThirdPartiesCurrent	300000	usd
CY2022Q2	GTLL	Notes Payable Third Parties Current NotesPayableThirdPartiesCurrent	387500	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	2250	usd
CY2022Q2	us-gaap	Loans Payable Current LoansPayableCurrent	2250	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	49863	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	568684	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1272799	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	981675	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1676087	usd
CY2022Q4	us-gaap	Liabilities Liabilities	981675	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1676087	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14991000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14991000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14488440097	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13785662319	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1448844	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1378566	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	162913727	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572382	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-947748	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	162732907	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	409293	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	728339	usd
CY2022Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	1385113	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14000	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	95000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	14000	usd
CY2021Q4	us-gaap	Gross Profit GrossProfit	45000	usd
	us-gaap	Gross Profit GrossProfit	14000	usd
	us-gaap	Gross Profit GrossProfit	95000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	10000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20000	usd
CY2022Q4	us-gaap	Officers Compensation OfficersCompensation	20000	usd
CY2021Q4	us-gaap	Officers Compensation OfficersCompensation	20000	usd
	us-gaap	Officers Compensation OfficersCompensation	334467	usd
	us-gaap	Officers Compensation OfficersCompensation	90087	usd
CY2022Q4	us-gaap	Depreciation Depreciation	1298	usd
CY2021Q4	us-gaap	Depreciation Depreciation	1299	usd
	us-gaap	Depreciation Depreciation	2596	usd
	us-gaap	Depreciation Depreciation	2598	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	6900	usd
CY2021Q4	us-gaap	Professional Fees ProfessionalFees	25318	usd
	us-gaap	Professional Fees ProfessionalFees	27800	usd
	us-gaap	Professional Fees ProfessionalFees	45980	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10314	usd
CY2021Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42934	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12669	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59252	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	38512	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	89551	usd
	us-gaap	Operating Expenses OperatingExpenses	377532	usd
	us-gaap	Operating Expenses OperatingExpenses	197917	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-24512	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-44551	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-363532	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-102917	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	4411	usd
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	277	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	8822	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	277	usd
CY2021Q4	GTLL	Forgiveness Of Debt And Accrued Interest ForgivenessOfDebtAndAccruedInterest	15445	usd
	GTLL	Forgiveness Of Debt And Accrued Interest ForgivenessOfDebtAndAccruedInterest	449294	usd
CY2022Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	211387	usd
CY2021Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	560912	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	544017	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	562995	usd
CY2021Q4	GTLL	Gain Loss On Issuance On Notes Payable GainLossOnIssuanceOnNotesPayable	32309	usd
	GTLL	Gain Loss On Issuance On Notes Payable GainLossOnIssuanceOnNotesPayable	154355	usd
CY2022Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7562	usd
CY2021Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	12673	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	15176	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	41656	usd
CY2021Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	154789	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	49863	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	261682	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	208236	usd
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	376863	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	487800	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	554873	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	183724	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	332312	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	124268	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	451956	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	183724	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	332312	usd
	us-gaap	Net Income Loss NetIncomeLoss	124268	usd
	us-gaap	Net Income Loss NetIncomeLoss	451956	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	14488440097	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	12024696496	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	14383434078	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	13280935552	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-925419	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	740150	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	206382	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	332312	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	353425	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-756106	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	183724	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572382	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1045063	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	740150	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	206382	usd
	us-gaap	Net Income Loss NetIncomeLoss	451956	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	353425	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-947748	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-947748	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	251098	usd
	us-gaap	Net Income Loss NetIncomeLoss	124268	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572382	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572382	usd
	us-gaap	Net Income Loss NetIncomeLoss	124268	usd
	us-gaap	Net Income Loss NetIncomeLoss	451956	usd
	GTLL	Gain From Forgiveness Of Debt And Interest GainFromForgivenessOfDebtAndInterest	449294	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	544017	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	562995	usd
	GTLL	Loss On Issuance On Notes Payable LossOnIssuanceOnNotesPayable	154355	usd
	us-gaap	Depreciation Depreciation	2596	usd
	us-gaap	Depreciation Depreciation	2598	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	49863	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	261682	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	40000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	8822	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	277	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-12000	usd
	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-847	usd
	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	14598	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	17590	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1395	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	15176	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	48042	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	18074	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-324425	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-137926	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	150000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-150000	usd
	GTLL	Proceeds From Issuance Of Stock For Regulation Financing ProceedsFromIssuanceOfStockForRegulationFinancing	740150	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	405	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	26597	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	136250	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	849398	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-324425	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	561472	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	324494	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56300	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	617772	usd
	GTLL	Cancellation Of Common Stock And Stock To Be Issued CancellationOfCommonStockAndStockToBeIssued	68000	usd
	GTLL	Cancellation Of Common Stock As Per Court Order CancellationOfCommonStockAsPerCourtOrder	299100	usd
	GTLL	Issuance Of Common Stock For Debt And Accrued Interest IssuanceOfCommonStockForDebtAndAccruedInterest	206382	usd
CY2022Q1	GTLL	Agreement Description AgreementDescription	the Company shall pay Donohoe an initial retainer in the amount of $17,500 and if successful a “success fee”
CY2022Q1	GTLL	Success Fee Amount SuccessFeeAmount	10000	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_805_eus-gaap--BasisOfAccounting_z3GGMcQ0qNcg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE B – <span id="xdx_82E_zMqQS4ixNyy">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of December 31, 2022 and the results of operations, changes in stockholders’ equity, and cash flows for the periods presented. The results of operations for the three and six months ended December 31, 2022 are not necessarily indicative of the operating results for the full fiscal year or any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022 as filed with the Securities and Exchange Commission on October 13, 2022. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2022, and updated, as necessary, in this Quarterly Report on Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLOBAL TECHNOLOGIES, LTD</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>For the six months ended December 31, 2022 and 2021</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Unaudited)</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> </p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zicDCux9eDjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zOLbuRdUnS4f">Concentrations of Risks</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Concentration of Accounts Receivable</span></i> –At December 31, 2022 and June 30, 2022, the Company had $<span id="xdx_900_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_do_c20221231_zSXTw3icxaxh" title="Accounts receivables">5,000</span> and $<span id="xdx_904_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20220630_zvaHgtjm5Kuf" title="Accounts receivables">5,000</span> in accounts receivable, respectively. For the six months ended December 31, 2022, one customer accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zd51fuOrdJe6" title="Concentration risk percentage">100</span>% of accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Concentration of Revenues</span></i> – For the six months ended December 31, 2022, the Company generated $<span id="xdx_902_eus-gaap--Revenues_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zsAFXTKXVSN4" title="Revenues">14,000</span> in revenue from one customer. For the six months ended December 31, 2021, the Company generated $<span id="xdx_90F_eus-gaap--Revenues_c20210701__20211231_zCXClHjyiS3j" title="Revenues">95,000</span> revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="background-color: white"><i><span style="text-decoration: underline">Concentration of Suppliers</span></i> – The Company relies on a limited number of suppliers and contract manufacturers. In particular, a single supplier is currently the sole manufacturer of the Company’s CBD products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Concentration of Loans Receivable, Other</span></i> –At December 31, 2022 and June 30, 2022, the Company had $<span id="xdx_907_eus-gaap--OtherReceivablesNetCurrent_iI_do_c20221231__srt--MajorCustomersAxis__custom--OneBorrowerMember_zRxnFRzgEfAa" title="Loans receivables other">17,533</span> and $<span id="xdx_904_eus-gaap--OtherReceivablesNetCurrent_iI_do_c20220630__srt--MajorCustomersAxis__custom--OneBorrowerMember_zWD6biOvFqt4" title="Loans receivables other">18,380</span> in loans receivable, other. At December 31, 2022 and June 30, 2022, one borrower accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--NotesReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneBorrowerMember_zAMQ3k1gLhB6" title="Concentration risk percentage"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--NotesReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneBorrowerMember_z2xu8kDVcO62" title="Concentration risk percentage">100</span></span>% of the Company’s total loans receivable, other. The one borrower is controlled by the Company’s sole officer and director.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="background-color: white"><i><span style="text-decoration: underline">Concentration of Notes Receivable </span></i>– The Company had notes receivable of $<span id="xdx_905_eus-gaap--NotesAndLoansReceivableNetNoncurrent_iI_do_c20221231__srt--MajorCustomersAxis__custom--OneBorrowerMember_z8GyGUoc3hm3" title="Notes receivable">350,000</span> and $<span id="xdx_903_eus-gaap--NotesAndLoansReceivableNetNoncurrent_iI_do_c20220630__srt--MajorCustomersAxis__custom--OneBorrowerMember_zgQ8p5Wk8Yl8" title="Notes receivable">350,000</span> at December 31, 2022 and June 30, 2022, respectively. At December 31, 2022, one borrower accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--NotesReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneBorrowerMember_zR4ZtzpEOFoa" title="Concentration risk percentage">100</span>% of the Company’s total notes receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	5000	usd
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	5000	usd
	us-gaap	Revenues Revenues	95000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33600000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1500660030	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zn6cKkJKieL9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_z8VofUSk6MTf">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	546411	usd
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	70580	usd
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	36363	usd
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	653354	usd
CY2019Q4	us-gaap	Goodwill Goodwill	1346646	usd
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	2000000	usd
CY2019Q4	us-gaap	Goodwill Goodwill	1346646	usd
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	-1346646	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	473323	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36363	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36363	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16015	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13419	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20348	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22944	usd
	us-gaap	Depreciation Depreciation	2596	usd
	us-gaap	Depreciation Depreciation	2598	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	350000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	18074	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	300000	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	387500	usd
CY2022	GTLL	Forgiveness Of Debt Including Accrued Interest ForgivenessOfDebtIncludingAccruedInterest	449293	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	568684	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1272799	usd
	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	All shares of the Series K Super Voting Preferred Stock shall rank (i) senior to the Corporation’s (A) Common Stock, par value $0.0001 per share (“Common Stock”), and any other class or series of capital stock of the Corporation hereafter created, except as otherwise provided in clauses (ii) and (iii) of this Section 4, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series K Super Voting Preferred-Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series K Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	The holders of the Class A Shares and the Class B Shares shall vote as a single class on all matters submitted to a vote of the stockholders, with each Class A Share being entitled to one (1) vote and each Class B Share being entitled to six (6) votes, except as otherwise provided by law
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166320069	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-324425	usd

Files In Submission

Name	View Source	Status
gtll-20221231_def.xml	Edgar Link	unprocessable
gtll-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
gtll-20221231_lab.xml	Edgar Link	unprocessable
0001493152-23-005657-index-headers.html	Edgar Link	pending
0001493152-23-005657-index.html	Edgar Link	pending
0001493152-23-005657.txt	Edgar Link	pending
0001493152-23-005657-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
gtll-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gtll-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTLL
GLOBAL TECHNOLOGIES LTD Stock $gtll

2023 Q1 Form 10-Q Financial Statement

#000149315223005657 Filed on February 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTLL GLOBAL TECHNOLOGIES LTD Stock $gtll

2023 Q1 Form 10-Q Financial Statement

#000149315223005657 Filed on February 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTLL
GLOBAL TECHNOLOGIES LTD Stock $gtll